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Introduction 
 
Theoretical background of the study 
Cognition, as a psychological concept basically means the 
process of getting and assimilating all kind of information. 
Within cognition, social cognition and neurocognition in 
schizophrenia are widely investigated with different 
methods and in various study designs. The impairment of 
these fields and their relationship with social functioning is 
well known in schizophrenia. Neurocognition is any form 
of the basic cognitions, which are linked to the 
functioning of specific areas of the brain. Social cognition 
defines how people think about themselves and others in the 
social world. It includes all the social and emotional skills 
that are needed for successful interpersonal interactions. 
Theory of mind (ToM) or mentalization, emotion 
recognition ability, attributional style, social knowledge and 
social perception are the five primary domains of social 
cognition. Theory of mind (ToM) is the ability to attribute 
mental states to the self and others. This ability helps to 
represent the different mental states of others in order to 
deduce others' intentions, desires and thoughts. It includes 
understanding false beliefs, intentions, deception, hints, 
irony, faux pas and metaphor.  
Schizophrenia is often considered as a disease of the brain, and 
impaired cognitive functioning is a core symptom of the illness 
and a dominant part of the symptomatology. Several studies 
have described that patients with schizophrenia are 
characterized by marked cognitive deficits, mainly in the 
areas of attention, visual memory, working memory and 
executive functions. Their cognitive performance is 
consistently worse compared to healthy individuals in certain 
tests measuring neurocognitive functions. Many studies 
about ToM also described that patients with schizophrenia 
have shown deficits in this ability compared to healthy and 
other psychiatric controls. The present dissertation is 
engaged in social- and neurocognitive skills of patients with 
schizophrenia within the cognitive skills of these patients. 
Longitudinally, schizophrenia is usually characterized by 
different episodes, i.e. periodic relapses and remission phases. 
During relapse, patients with schizophrenia show specific 
psychotic symptoms, while the remission state is mainly 
characterized by milder and predominantly negative symptoms.  
Unfortunately, remissions are usually time-limited periods in 
the course of schizophrenia. Nevertheless, being in symptomatic 
remission does not mean that patients are doing completely well, 
since the remaining milder symptoms may negatively affect their 
functioning. 
Controversy exists in the literature regarding cognitive 
functioning in schizophrenia. In several studies patients in 
remission have shown improved executive functioning 
compared to those in relapse. Another research found only 
weak correlation between improved symptoms and changes 
in cognitive dysfunctions. These studies were characterized 
by a cross-sectional design. In several longitudinal studies, it 
has been concluded that the neurocognitive performance of 
patients with schizophrenia is notably stable regardless of 
clinical state, mentioning the trait-like characteristics of the 
disorder. Furthermore, previously no significant differences in 
neurocognitive performance of patients with schizoaffective 
disorder between relapse and remission were reported, which 
also suggests its trait-like nature.  
Some earlier investigations did not find ToM deficits in 
remitted patients. The majority of recent investigations 
found that ToM deficits are present also in remission. The 
trait-like components of ToM deficits are further 
supported by studies that found that healthy siblings and 
first-degree relatives of patients with schizophrenia 
performed worse on ToM tests than non-relative healthy 
controls, but better than patients. 
However, only a few studies examined ToM in a longitudinal 
setting. A recent study found that deficits in ToM are 
relatively stable in time, but not fully independent of 
symptom state: ToM impairments were present during 
acute and also in relatively remitted phases, but more salient 
during symptomatic periods. The trait features of the 
illness were also confirmed. These longitudinal studies not 
only examined ToM during a longer period of time (6–12 
months), but also emphasized that subjects were in a 
relatively stable state at all visits.  
Several studies found that the impairment of emotion 
perception among patients with schizophrenia is also a 
significant feature of the illness. Individuals with 
schizophrenia show deficits in emotion recognition 
compared with healthy controls. Previous studies suggest 
that patients in remission may perform better in emotion 
recognition than patients in relapse, while others found that 
emotion recognition is stable over time in schizophrenia. In 
another study healthy siblings performed better than 
patients but worse than controls on emotion identification 
and discrimination tests, which promotes the hypothesis of 
the trait-like nature of emotion recognition deficits. 
 
Aims of the study 
The wide literature of cognition considers the social-, and 
neurocognition as different fields but their detachment 
regarding their functioning is in question. Linked to this and to 
the controversy results of studies in the literature regarding the 
state-, or trait characteristics of cognitive skills a question has 
been expressed that the deficits mentioned above are trait-like 
(always present during the patient’s life) or state-like (appear 
due to relapse, and their existence and severity depend on the 
patient’s actual state) and if there is difference between the 
two fields in this aspect.  
Based on literature date it may be hypothesized that 
fluctuation of symptom severity has different impact on the 
examined fields, thus it influences the neurocognitive 
functioning less, but has more effect on social cognition. Our 
hypothesis is that the changing of social cognition as a highly 
organized complex cognitive function more tightly linked to 
the changing of clinical symptoms (typically state-like) than 
the more basic neurocognitive functions (typically trait-like). 
The sensitivity of ToM or emotion recognition within social 
cognition to the changes in symptom state is uncertain. ToM 
as a more complex function expectedly fluctuates with the 
state more significantly. In addition, we suppose the existence 
of trait-like components in all of the tested functions, which 
can be concluded the chronic nature of the disease. 
Based on the mentioned above our aims were the follows: 
Evaluation of ToM and emotion recognition skills in patients 
with schizophrenia with RMET and FEEST in acute then in 
clinically stable state. Investigating correlations between the 
tests and changing of clinical state. 
Evaluation of neurocognitive skills in patients with 
schizophrenia with CANTAB test in acute then in clinically 
stable state. Investigating relations between neurocognitive 
functions and changing of clinical symptoms. 
Associations between social cognition, neurocognitive skills 
and the effect of changing of psychotic symptom severity on 
these functions. 
Determining the state-, and trait nature in social-, and 
neurocognitive functions with the applied tests.  
 
Materials and methods 
Patients with schizophrenia meeting the DSM-IV criteria took 
part in our study. Patients were recruited from the inpatient 
units of the University of Debrecen Medical and Health 
Science Center, Department of Psychiatry, Debrecen, 
Hungary. Exclusion criteria were the following: any severe 
somatic illness, drug or alcohol addiction or abuse, major 
depressive disorder and schizoaffective disorder in the 
lifespan. Research diagnosis was based on diagnostic 
interviews guided by clinicians independent of this study. 
These interviews included the Structured Clinical Interview 
for DSM Disorders — Clinician Version (SCID-CV) and 
Research Version (SCID-RV). Age-matched control persons 
were healthy individuals who had no history of any psychiatric 
disorder or family history of psychosis. None of the control 
subjects had a history of substance abuse (alcohol, THC, 
hallucinogens, cocaine, opiates, inhalants, methamphetamines 
or other stimulants), which could potentially influence their 
performance. Furthermore, none of the control subjects took 
antipsychotics or other psychotropic medications like 
benzodiazepines (BZDs), antidepressants or mood stabilizers. 
All participants signed a written consent form. The study was 
performed in accordance with The Code of Ethics of the 
World Medical Association (Declaration of Helsinki) for 
experiments involving humans, and it was approved by the 
Regional and Institutional Ethics Committee.   
Patients and healthy subjects were tested with the RMET 
(Reading the Mind in the Eyes Test) assessing 
mentalization ability, the ‘Ekman 60 Faces Test’ (Facial 
Expressions of Emotion: - Stimuli and Test (FEEST)) 
measuring emotion recognition skill, and CANTAB 
(Cambridge Neuropsychological Test Automated Battery) 
measuring neurocognitive skills. 
In order to assess symptom severity among patients the 
PANSS (Positive and Negative Syndrome Scale) was used by 
a trained psychologist, who assessed all patients. 
Patients were examined twice - first in an acute phase (as 
soon as they were able to cooperate, on average within 4 days 
after admission), and for the second time in a clinically 
stable state. The clinically stable state was defined as being 
discharged by the patient's physician from the inpatient 
ward and being treated as an outpatient therein after. 
Controls were tested only once, since we assumed that their 
performance would be stable over time due to the 
disposition of the tests — there was no feedback about the 
correctness of the given answers at all. 
Furthermore, the subgroups of patients in negative and 
positive symptomatic remission (PSR and NSR) were also 
defined in our investigation according to the criteria published 
by the Remission in Schizophrenia Working Group (RSWG). 
Patients were categorized into these subgroups according to 
their PANSS scores: (1) Positive symptomatic remission 
(PSR) was defined as ≤ 3 on the following items: P1, P2, P3, 
G5 and G9. (2) Negative symptomatic remission (NSR) was 
defined as ≤ 3 on items N1, N4, and N6. Emotion recognition 
and ToM in the subgroup of patients in NSR were also 
compared to healthy controls at the second visit. 
 
 
Results 
Social cognition (RMET, FEEST):  
There was a significant improvement in psychotic symptom 
severity between study visits. At the second visit 22 
subjects reached the criteria for PSR, and 15 patients reached 
the criteria for NSR. Healthy controls outperformed patients 
at baseline. Patients showed a marked improvement in ToM 
at the second assessment. Subjects with schizophrenia still 
performed worse in the clinically stable state than 
controls. The subgroup of patients at the second visit who 
fulfilled the criteria for NSR did not differ significantly from 
healthy controls at the second visit. Based on our results 
mentalization has also trait-and state-like components. 
There was a strong and constant negative correlation between 
negative symptom severity and RMET total score at both 
assessments. Only at the second assessment did the PANSS 
total and general symptom score correlate significantly 
with the RMET total score. No correlation was found 
between positive symptom score, antipsychotic medication 
dose, benzodiazepine dose or RMET at any visit.  
Patients showed a marked improvement also in emotion 
recognition at the second assessment. Subjects with 
schizophrenia still performed worse in the clinically stable 
state than controls. Healthy controls also outperformed the 
subgroup of patients who fulfilled the criteria for NSR at 
the second visit. 
There was a significant relationship between negative 
symptom severity and emotion recognition total score at 
both assessments. Emotion recognition did not correlate with 
antipsychotic medication dose, benzodiazepine dose, PANSS 
total or general symptom scores. Our results suggest that 
emotion recognition also has state-and trait-like characteristics in 
schizophrenia.  
Emotion recognition as indexed by the FEEST and ToM as 
indexed by the RMET showed a very strong positive 
correlation at both study visits in the patient group, which 
supports the notion that emotion recognition and 
mentalization are all part of social cognition and influence 
each other through different processes. 
 
Neurocognition (CANTAB): 
Patients showed significantly worse performance in all of the 
administered CANTAB tests (SRM, PAL, SWM, SOC, RVP) 
compared to healthy controls in both states (relapse and 
clinically stable state).   
The overall sum of the positive symptoms of PANSS were 
correlated with the performance of patients in the SWM subtest 
in acute phase. Negative symptoms were significantly 
correlated with PAL and SRM. General symptoms of PANSS 
also correlated with the PAL (paired associated learning) 
during relapse and in clinically stable state. There was no 
correlation between the positive symptoms of PANSS and any 
of the subtests in clinically stable state.  
Our results suggest that the neurocognitive dysfunctions are 
persistent in all phases of the disorder and may represent the 
core symptom of the disease. 
 
Associations between the specific domains of neurocognition 
and social cognition 
In line with previous findings in literature social cognition and 
neurocognition are related domains, we also found correlation 
between PAL and the tests measuring ToM and emotion 
recognition in acute phase, while SRM was correlated with 
emotion recognition in clinically stable state. PAL and 
emotion recognition was still correlated in clinically stable 
state.  
 
 
 
 
 
 
Conclusions 
The relevance of the dissertation is assessing social cognition 
and neurocognition among patients with schizophrenia in 
acute and clinically stable state. The deficit of social cognition 
and neurocognition in schizophrenia is clear in our study 
according to previous literature data. We also found that 
measuring the two components of social cognition with the 
applied tests these functions are mostly state-like, while the 
more basic neurocognitive skills are trait-like. The results 
support our hypothesis that changes of social cognition as a 
complex cognitive function more tightly linked to the changes of 
clinical symptoms (more state-like) than the primary 
neurocognitive functions (more trait-like). Furthermore, ToM as a 
more complex function fluctuated more with the state of illness, 
which difference between ToM and emotion recognition supports 
that ToM has a higher level of functioning. Our results also 
showed that social cognition has trait-like component, because 
ToM and emotion recognition were still found to be impaired 
even in clinically stable state compared to healthy controls.  
Neurocognitive impairment exists during both states 
suggesting that these deficits might be permanent, although 
there can be a mild improvement in some cognitive fields. 
We also found relationship between neurocognition and 
social cognition, which proved that these domains are related 
in line with previous studies.                                                 
According to our results, PAL test showed significant 
correlations with PANSS negative symptoms and with all 
tests measuring social cognition, thus it can be concluded 
that PAL is the most sensitive test of global functioning. It 
could be used as an early screening method due to its utility 
of detecting early dysfunctions. Finally, the social cognition 
can be improved in schizophrenia, therefore it may be the 
target of some rehabilitation programs.  
 
 
 
 
 
 
 
